CRF receptor antagonist astressin-B reverses and prevents alopecia in CRF over-expressing mice

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Wang, Lixin ^a   Million, Mulugeta ^a   Rivier, Jean ^b   Rivier, Catherine ^b   Craft, Noah ^a   Stenzel Poore, Mary P ^c   Taché, Yvette ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; ASTRESSIN 2B; ASTRESSIN B; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; MINOXIDIL SULFATE; PEPTIDE HORMONE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; HORMONE ANTAGONIST; PEPTIDE FRAGMENT;

ADRENAL GLAND WEIGHT; ALOPECIA; ANAPHASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CUSHING SYNDROME; DRUG EFFECT; DRUG MECHANISM; FEMALE; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; HISTOLOGY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BLOCKING; SKIN PIGMENTATION; VISCERAL FAT WEIGHT; WEIGHT; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; DRUG SCREENING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAIR; INTRAPERITONEAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSGENIC MOUSE; UPREGULATION;

MURINAE; MUS;

ALOPECIA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DRUG EVALUATION, PRECLINICAL; FEMALE; HAIR; HORMONE ANTAGONISTS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; UP-REGULATION;

EID: 79951924738     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016377     Document Type: Article

References (38)

1. Selye H, (1950) The Physiology and Pathology of Exposure to Stress Montreal ACTA Inc. Medical Publishers.
2. Arck PC, Slominski A, Theoharides TC, Peters EM, Paus R, (2006) Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 126: 1697-1704.
3. Peters EM, Arck PC, Paus R, (2006) Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp Dermatol 15: 1-13.
4. Botchkarev VA, (2003) Stress and the hair follicle: exploring the connections. Am J Pathol 162: 709-712.
5. Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, et al. (2005) Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 19: 1332-1334.
6. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, et al. (2001) Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 15: 1678-1693.
7. Zhang X, Yu M, Yu W, Weinberg J, Shapiro J, et al. (2009) Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol 129: 1527-1538.
8. Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz JE, Wortsman J, (2004) Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 145: 941-950.
9. Slominski A, Wortsman J, Tuckey RC, Paus R, (2007) Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol 265-266: 143-149.
10. Coste SC, Murray SE, Stenzel-Poore MP, (2001) Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides 22: 733-741.
11. Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W, (1992) Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130: 3378-3386.
12. Stenzel-Poore MP, Duncan JE, Rittenberg MB, Bakke AC, Heinrichs SC, (1996) CRH overproduction in transgenic mice: behavioral and immune system modulation. Ann N Y Acad Sci 780: 36-48.
13. Million M, Wang L, Stenzel-Poore MP, Coste SC, Yuan PQ, et al. (2007) Enhanced pelvic responses to stressors in female CRF-overexpressing mice. Am J Physiol Regul Integr Comp Physiol 292: R1429-R1438.
14. Dirks A, Groenink L, Bouwknecht JA, Hijzen TH, Van Der GJ, et al. (2002) Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations. Eur J Neurosci 16: 1751-1760.
15. Stengel A, Goebel M, Million M, Stenzel-Poore MP, Kobelt P, et al. (2009) Corticotropin-releasing factor-overexpressing mice exhibit reduced neuronal activation in the arcuate nucleus and food intake in response to fasting. Endocrinology 150: 153-160.
16. Goebel M, Fleming SM, Million M, Stengel A, Taché Y, et al. (2010) Mice overexpressing corticotropin-releasing factor show brain atrophy and motor dysfunctions. Neurosci Lett.
17. Porter RM, (2003) Mouse models for human hair loss disorders. J Anat 202: 125-131.
18. Wood GA, Flenniken A, Osborne L, Fleming C, Vukobradovic I, et al. (2005) Two mouse mutations mapped to chromosome 11 with differing morphologies but similar progressive inflammatory alopecia. Exp Dermatol 14: 373-379.
19. Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, et al. (1999) Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci 885: 287-311.
20. Rivier JE, Kirby DA, Lahrichi SL, Corrigan A, Vale WW, et al. (1999) Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat. J Med Chem 42: 3175-3182.
21. Chen C, (2006) Recent advances in small molecule antagonists of the corticotropin-releasing factor type-1 receptor-focus on pharmacology and pharmacokinetics. Curr Med Chem 13: 1261-1282.
22. Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, et al. (2002) Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem 45: 4737-4747.
23. Messenger AG, Rundegren J, (2004) Minoxidil: mechanisms of action on hair growth. Br J Dermatol 150: 186-194.
24. Roloff B, Fechner K, Slominski A, Furkert J, Botchkarev VA, et al. (1998) Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J 12: 287-297.
25. Wang L, Martinez V, Rivier JE, Taché Y, (2001) Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am J Physiol Regul Integr Comp Physiol 281: R1401-R1410.
26. Slominski A, Wortsman J, Plonka PM, Schallreuter KU, Paus R, et al. (2005) Hair follicle pigmentation. J Invest Dermatol 124: 13-21.
27. Paus R, (2010) A neuroendocrinological perspective on human hair follicle pigmentation *. Pigment Cell Melanoma Res.
28. Tobin DJ, Kauser S, (2005) Hair melanocytes as neuro-endocrine sensors-pigments for our imagination. Mol Cell Endocrinol 243: 1-11.
29. Slominski A, Baker J, Ermak G, Chakraborty A, Pawelek J, (1996) Ultraviolet B stimulates production of corticotropin releasing factor (CRF) by human melanocytes. FEBS Lett 399: 175-176.
30. Kauser S, Slominski A, Wei ET, Tobin DJ, (2006) Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides. FASEB J 20: 882-895.
31. Slominski A, Zbytek B, Zmijewski M, Slominski RM, Kauser S, et al. (2006) Corticotropin releasing hormone and the skin. Front Biosci 11: 2230-2248.
32. Slominski A, Paus R, (1993) Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol 101: 90S-97S.
33. Harrison S, Bergfeld W, (2009) Diffuse hair loss: its triggers and management. Cleve Clin J Med 76: 361-367.
34. Vegesna V, O'Kelly J, Uskokovic M, Said J, Lemp N, et al. (2002) Vitamin D3 analogs stimulate hair growth in nude mice. Endocrinology 143: 4389-4396.
35. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, et al. (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20: 1093-1102.
36. Turnbull AV, Smith GW, Lee S, Vale WW, Lee KF, et al. (1999) CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation. Endocrinology 140: 1013-1017.
37. Martinez V, Wang L, Rivier JE, Vale W, Taché Y, (2002) Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther 301: 611-617.
38. Shirai A, Ikeda J, Kawashima S, Tamaoki T, Kamiya T, (2001) KF19418, a new compound for hair growth promotion in vitro and in vivo mouse models. J Dermatol Sci 25: 213-218.